Loncar & Associates investigating Uloric
Gout medication linked to cardiac death, heart attack and stroke
Approved in 2009, Takeda’s blockbuster, Uloric (febuxostat) was designed to treat gout and symptoms of arthritis associated with hyperuricemia. According to the FDA, gout impacts over 8 million Americans. Unfortunately, there are a limited number of medications available to treat the pain and inflammation associated with gout. When approved in 2009, it was the first new gout medication to come along in 40 years.
The medication has been monitored by Loncar & Associates for product-liability litigation since 2015 because of the associated risks of strokes, heart attacks, tachycardia, cardiac arrest, acute myocardial infarction and other acute cardiovascular injuries. Takeda originally sought and was denied FDA approval in 2005 for fear of cardiovascular side effects. After additional studies, the FDA granted approval in 2009. However, Takeda was forced to include a warning of cardiovascular events in the Warnings and Precautions section of the labeling information.
On February 21, 2019, the FDA required Takeda to add a black box warning regarding heart-related death to patients using Uloric. A black box warning is the highest level of warning the FDA can add to a medicine’s labeling information. It means the FDA believes there is a reasonable evidence of a link between a medication and the side effect.
Experienced Attorneys Fighting for Maximum Compensation for our Clients
What Takeda knew and when they knew it will have a major impact on this litigation. In addition, the updated labeling information likely triggers the statute of limitations for people already injured by the drug. The statute of limitations is the time limit in which a lawsuit must be filed. Failure to file suit within the time limit usually prevents a person from any financial recovery. It can take 6 months or more to fully investigate an individual case for litigation. In a handful of states the time limit to file suit can be as short as 1 year. Those injured by Takeda need to take legal action immediately! Your time may already be running out to file suit. Do not miss out on the compensation you deserve.
Loncar & Associates has been handling pharmaceutical and medical device injury claims since 1999, successfully litigating thousands of cases nationwide for victims of the pharmaceutical industry putting profits ahead of safety. The personal injury attorneys at Loncar & Associates are admitted handle pharmaceutical and medical device cases in 15 federal courts nationwide and we are eligible to practice in any federal court that would be assigned the Uloric litigation.
The pharmaceutical companies spare no expense in selling you these dangerous medications. Likewise, they spare no expense in defending their profits from personal injury litigation. Your case is too important to trust to a referral service or inexperienced law firm. Our clients have collected tens of millions over the last two decades for their injuries.
If you or someone you love has been the victim of Takeda’s greed and suffered a cardiovascular injury requiring hospitalization or a stroke while using Uloric, choose a law firm that cares about you and your injuries. Choose a lawyer who never charges a fee without a successful outcome. Choose an experienced attorney with the power and guts to take-on big pharma and win your case. Choose a law firm with thousands of satisfied clients across America. Choose Loncar & Associates.
Call 800-285-4878 anytime or complete the contact form for a free no-obligation consultation to get the compensation you deserve.